Skip to Content

Naratriptan use while Breastfeeding

Drugs containing Naratriptan: Amerge

Medically reviewed by Drugs.com. Last updated on Jul 27, 2020.

Naratriptan Levels and Effects while Breastfeeding

Summary of Use during Lactation

Because there is little published experience with naratriptan during breastfeeding, other agents may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. One woman who was over 1 month postpartum using naratriptan to treat migraine provided milk samples at intervals over a 24-hour period after a single dose. The authors estimated the weight-adjusted infant dosage to be 5%.[1]

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Eletriptan, Rizatriptan, Sumatriptan, Zolmitriptan

References

1.
Amundsen S, Nordeng H, Fuskev├ąg OM, et al. Transfer of triptans into human breast milk and estimation of infant drug exposure through breastfeeding. Reprod Toxicol. 2019;88:141. [CrossRef]

Substance Identification

Substance Name

Naratriptan

CAS Registry Number

121679-13-8

Drug Class

Breast Feeding

Lactation

Serotonin Agonists

Vasoconstrictor Agents

Serotonin 5-HT1 Receptor Agonists

Triptans

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.